REVANCE THERAPEUT.DL-,001

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange REVANCE THERAPEUT.DL-,001 stocks are traded under the ticker RTI.

REVANCE THERAPEUT.DL-,001 is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

RTI earnings for the last quarter are −0.37 EUR per share, whereas the estimation was −0.66 EUR resulting in a 44.16% surprise. The estimated earnings for the next quarter are −0.59 EUR per share. See more details about REVANCE THERAPEUT.DL-,001 earnings.

REVANCE THERAPEUT.DL-,001 revenue for the last quarter amounts to ‪53.71 M‬ EUR despite the estimated figure of ‪55.25 M‬ EUR. In the next quarter revenue is expected to reach ‪56.28 M‬ EUR.

Yes, you can track REVANCE THERAPEUT.DL-,001 financials in yearly and quarterly reports right on TradingView.

No, RTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, RTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REVANCE THERAPEUT.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.

RTI reached its all-time high on Nov 26, 2015 with the price of 37.34 EUR, and its all-time low was 0.68 EUR and was reached on Nov 4, 2010.
See other stocks reaching their highest and lowest prices.

As of Apr 30, 2024, the company has 597.00 employees. See our rating of the largest employees — is REVANCE THERAPEUT.DL-,001 on this list?

We've gathered analysts' opinions on REVANCE THERAPEUT.DL-,001 future price: according to them, RTI price has a max estimate of 27.92 EUR and a min estimate of 5.58 EUR. Read a more detailed REVANCE THERAPEUT.DL-,001 forecast: see what analysts think of REVANCE THERAPEUT.DL-,001 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REVANCE THERAPEUT.DL-,001 EBITDA is ‪−187.57 M‬ EUR, and current EBITDA margin is −88.46%. See more stats in REVANCE THERAPEUT.DL-,001 financial statements.